4//SEC Filing
Pimblett Emily 4
Accession 0000950170-24-108582
CIK 0001768446other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 9:53 PM ET
Size
10.4 KB
Accession
0000950170-24-108582
Insider Transaction Report
Form 4
Pimblett Emily
SVP, Finance & CAO
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-09-18−5,000→ 30,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-09-18+5,000→ 8,755 total - Sale
Common Stock
2024-09-20$8.18/sh−1,182$9,669→ 7,573 total - Sale
Common Stock
2024-09-20$8.06/sh−9$73→ 7,564 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
- [F2]The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.
Documents
Issuer
Eliem Therapeutics, Inc.
CIK 0001768446
Entity typeother
Related Parties
1- filerCIK 0001969365
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 9:53 PM ET
- Size
- 10.4 KB